Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Amy Franks

Concepts (190)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Education, Pharmacy
18
2024
144
8.250
Why?
Schools, Pharmacy
8
2024
52
3.520
Why?
Pharmacy
3
2023
53
2.040
Why?
Writing
4
2024
42
1.740
Why?
Students, Pharmacy
5
2024
120
1.660
Why?
Faculty
7
2024
71
1.240
Why?
Professional-Patient Relations
3
2019
49
1.230
Why?
Teaching
4
2024
112
1.070
Why?
Educational Measurement
6
2019
196
0.980
Why?
Career Choice
1
2024
112
0.850
Why?
Students
3
2024
219
0.840
Why?
Pharmaceutical Services
2
2023
50
0.840
Why?
Learning
2
2024
155
0.800
Why?
Fellowships and Scholarships
2
2020
120
0.790
Why?
Humans
43
2024
50419
0.780
Why?
Pharmacies
1
2023
60
0.760
Why?
Biomedical Research
1
2024
243
0.730
Why?
Patient-Centered Care
2
2019
130
0.670
Why?
Motivational Interviewing
2
2019
32
0.660
Why?
Health Knowledge, Attitudes, Practice
4
2018
485
0.650
Why?
Program Development
2
2018
163
0.580
Why?
Blood Pressure
3
2012
525
0.580
Why?
Probucol
2
2009
3
0.570
Why?
Mass Screening
2
2011
343
0.560
Why?
Achievement
1
2017
37
0.550
Why?
Patient Education as Topic
2
2011
332
0.550
Why?
Perception
1
2017
115
0.530
Why?
Cross-Sectional Studies
7
2020
1601
0.500
Why?
Feedback
1
2016
53
0.500
Why?
Tetrazoles
2
2008
40
0.500
Why?
Antihypertensive Agents
2
2009
129
0.490
Why?
Hypertension
3
2009
545
0.470
Why?
Health Personnel
1
2017
251
0.460
Why?
Research Personnel
2
2024
65
0.420
Why?
Curriculum
5
2019
393
0.400
Why?
Community Health Services
2
2011
101
0.390
Why?
Energy Drinks
1
2012
6
0.390
Why?
Female
17
2024
27053
0.380
Why?
Caffeine
1
2012
64
0.370
Why?
Platelet Aggregation Inhibitors
2
2012
174
0.370
Why?
Faculty, Medical
2
2023
91
0.360
Why?
Coronary Disease
1
2011
153
0.350
Why?
Universities
2
2024
168
0.340
Why?
Cardiovascular Diseases
3
2012
464
0.340
Why?
Male
15
2024
25866
0.340
Why?
Adrenergic beta-Antagonists
1
2009
108
0.310
Why?
Cardiovascular System
1
2009
52
0.310
Why?
Biphenyl Compounds
1
2008
31
0.300
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
43
0.300
Why?
Benzimidazoles
1
2008
49
0.290
Why?
Thiazolidinediones
1
2007
82
0.270
Why?
Adult
11
2024
13561
0.260
Why?
Coronary Restenosis
1
2005
31
0.250
Why?
Hypoglycemic Agents
1
2007
174
0.240
Why?
Clinical Trials as Topic
4
2009
488
0.230
Why?
Program Evaluation
2
2024
351
0.220
Why?
Smoking
2
2018
506
0.220
Why?
Policy
1
2023
24
0.210
Why?
Career Mobility
1
2023
28
0.210
Why?
Organizational Policy
1
2023
39
0.210
Why?
Academies and Institutes
1
2023
17
0.210
Why?
Communication
2
2022
256
0.210
Why?
Checklist
1
2023
29
0.210
Why?
Angiotensin Receptor Antagonists
1
2003
18
0.200
Why?
Imidazoles
1
2003
125
0.190
Why?
Schools
1
2023
164
0.190
Why?
Angiotensin II
1
2003
159
0.190
Why?
Heart Failure
1
2007
531
0.180
Why?
Itraconazole
3
2008
41
0.180
Why?
Diabetes Mellitus, Type 2
1
2007
515
0.180
Why?
Amiodarone
1
2000
22
0.180
Why?
Qualitative Research
1
2023
351
0.180
Why?
Cannabis
1
2023
146
0.170
Why?
Anti-Arrhythmia Agents
1
2000
80
0.170
Why?
Mentors
1
2020
55
0.170
Why?
Blood Pressure Monitoring, Ambulatory
2
2012
36
0.170
Why?
Heart Arrest
2
2007
153
0.170
Why?
Self Report
1
2020
206
0.150
Why?
Peer Review
1
2018
9
0.150
Why?
Self-Assessment
2
2016
42
0.150
Why?
Pilot Projects
3
2009
694
0.150
Why?
Publishing
1
2018
40
0.140
Why?
Motivation
1
2020
277
0.140
Why?
Risk Factors
4
2011
3712
0.140
Why?
Knowledge
1
2017
27
0.140
Why?
Citrus paradisi
2
2008
10
0.130
Why?
Food-Drug Interactions
2
2008
14
0.130
Why?
Tobacco Products
1
2018
124
0.130
Why?
Education, Pharmacy, Graduate
1
2016
20
0.130
Why?
Pharmacists
3
2023
141
0.120
Why?
Arkansas
3
2023
1974
0.110
Why?
Middle Aged
7
2023
12579
0.110
Why?
Young Adult
3
2018
4075
0.110
Why?
Retrospective Studies
2
2024
6274
0.110
Why?
Antifungal Agents
2
2008
342
0.110
Why?
United States
2
2021
5005
0.100
Why?
Dose-Response Relationship, Drug
2
2008
1369
0.100
Why?
Ticlopidine
1
2012
53
0.100
Why?
Proton Pump Inhibitors
1
2012
83
0.090
Why?
Life Style
1
2011
145
0.090
Why?
Drug Interactions
3
2012
207
0.080
Why?
Atenolol
1
2009
13
0.080
Why?
Health Behavior
1
2011
253
0.080
Why?
Cerebrovascular Disorders
1
2009
53
0.080
Why?
Drug Tolerance
1
2009
59
0.080
Why?
Drug Evaluation, Preclinical
1
2009
144
0.080
Why?
Beverages
2
2008
56
0.070
Why?
Problem-Based Learning
1
2008
49
0.070
Why?
Education, Medical, Undergraduate
1
2008
84
0.070
Why?
Hirudins
1
2007
16
0.070
Why?
Anaphylaxis
1
2007
70
0.070
Why?
Edema
1
2007
69
0.070
Why?
Students, Medical
1
2008
157
0.060
Why?
Drugs, Investigational
1
2005
14
0.060
Why?
Weight Gain
1
2007
235
0.060
Why?
Insulin Resistance
1
2007
267
0.060
Why?
Molecular Structure
1
2005
293
0.060
Why?
Insulin
1
2007
464
0.060
Why?
Risk Assessment
1
2009
1268
0.060
Why?
Anticoagulants
1
2007
254
0.060
Why?
beta-Cyclodextrins
1
2004
16
0.060
Why?
Tachycardia, Ventricular
2
2003
43
0.060
Why?
Antioxidants
1
2005
237
0.050
Why?
Ephedra
1
2003
8
0.050
Why?
Electrocardiography, Ambulatory
1
2003
23
0.050
Why?
Phytotherapy
1
2003
46
0.050
Why?
Plant Preparations
1
2003
39
0.050
Why?
Receptors, Angiotensin
1
2003
11
0.050
Why?
Prescription Fees
1
2003
14
0.050
Why?
Hemostasis
1
2003
59
0.050
Why?
Adolescent
2
2018
6453
0.050
Why?
Animals
2
2009
13063
0.050
Why?
Practice Guidelines as Topic
2
2007
473
0.050
Why?
Hepatocytes
1
2003
179
0.050
Why?
Aged, 80 and over
1
2009
3233
0.050
Why?
Interleukin-6
1
2003
261
0.050
Why?
Ventricular Fibrillation
1
2000
16
0.040
Why?
Attitude of Health Personnel
1
2023
352
0.040
Why?
Aged
2
2012
9738
0.040
Why?
Attitude
1
2019
67
0.040
Why?
Dietary Supplements
1
2003
449
0.040
Why?
Cardiopulmonary Resuscitation
1
2000
138
0.040
Why?
Pregnant Women
1
2018
70
0.030
Why?
Liver
1
2003
1126
0.030
Why?
Risk
1
2018
325
0.030
Why?
Nicotine
1
2018
184
0.030
Why?
Pandemics
1
2021
553
0.030
Why?
Attitude to Health
1
2018
190
0.030
Why?
Societies, Pharmaceutical
1
2016
12
0.030
Why?
Pharmaceutical Solutions
2
2008
8
0.030
Why?
Child
1
2008
6931
0.030
Why?
Accreditation
1
2016
61
0.030
Why?
Area Under Curve
2
2008
179
0.030
Why?
Cross-Over Studies
2
2008
230
0.030
Why?
Time Factors
2
2012
2933
0.020
Why?
Regression Analysis
1
2012
376
0.020
Why?
Acute Coronary Syndrome
1
2012
76
0.020
Why?
Proportional Hazards Models
1
2012
416
0.020
Why?
Pregnancy
1
2018
2444
0.020
Why?
Cohort Studies
1
2012
1451
0.020
Why?
Peer Group
1
2008
56
0.020
Why?
Hospitalization
1
2012
677
0.020
Why?
Cytochrome P-450 CYP3A
1
2008
77
0.020
Why?
Risk Management
1
2007
31
0.020
Why?
Injections, Intravenous
1
2007
137
0.020
Why?
Follow-Up Studies
1
2012
2231
0.020
Why?
Antibodies
1
2007
151
0.020
Why?
Administration, Oral
1
2008
438
0.020
Why?
Renal Insufficiency
1
2007
109
0.020
Why?
Respiratory Insufficiency
1
2007
117
0.020
Why?
Recombinant Proteins
1
2007
477
0.020
Why?
Sex Factors
1
2008
718
0.020
Why?
Clinical Competence
1
2008
403
0.010
Why?
Cyclodextrins
1
2004
18
0.010
Why?
Biological Availability
1
2004
102
0.010
Why?
Ephedrine
1
2003
21
0.010
Why?
Cimetidine
1
2003
7
0.010
Why?
Receptors, Interleukin-6
1
2003
22
0.010
Why?
Diastole
1
2003
70
0.010
Why?
Bradycardia
1
2003
37
0.010
Why?
Systole
1
2003
72
0.010
Why?
Reference Values
1
2003
302
0.010
Why?
Cytochrome P-450 Enzyme System
1
2003
191
0.010
Why?
Patient Compliance
1
2003
232
0.010
Why?
Heart Rate
1
2003
304
0.010
Why?
Body Weight
1
2003
517
0.010
Why?
Enzyme Inhibitors
1
2003
369
0.010
Why?
Body Mass Index
1
2003
674
0.010
Why?
Cells, Cultured
1
2003
1563
0.010
Why?
Treatment Outcome
1
2003
5265
0.010
Why?
Franks's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description